Holen Sie sich die Stockscreener-App
3.02
3.42%
0.10
Schlusskurs vom Vortag:
$2.92
Offen:
$2.87
24-Stunden-Volumen:
547.79K
Relative Volume:
1.00
Marktkapitalisierung:
$176.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.31M
KGV:
-2.378
EPS:
-1.27
Netto-Cashflow:
$-62.80M
1W Leistung:
+10.62%
1M Leistung:
-31.83%
6M Leistung:
-35.88%
1J Leistung:
+31.88%
1-Tages-Spanne:
$2.79
$3.065
1-Wochen-Bereich:
$2.705
$3.065
52-Wochen-Spanne:
$2.2216
$6.1856
Rezolute Inc Stock (RZLT) Company Profile
Firmenname
Rezolute Inc
Sektor
Branche
Telefon
650-206-4507
Adresse
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Vergleichen Sie RZLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
3.02 | 176.76M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Eingeleitet | Wedbush | Outperform |
| 2024-08-27 | Eingeleitet | Guggenheim | Buy |
| 2024-07-17 | Eingeleitet | BTIG Research | Buy |
| 2024-06-04 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-09 | Eingeleitet | Maxim Group | Buy |
| 2022-08-02 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-27 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
Charles Schwab Investment Management Inc. Purchases 9,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Director Makes Bold Stock Purchase - TipRanks
Rezolute director Hogenhuis purchases $19,733 in common shares - Investing.com
rezolute CEO Elam Nevan buys $34,999 in common shares By Investing.com - Investing.com Australia
rezolute CEO Elam Nevan buys $34,999 in common shares - Investing.com
Rezolute’s CFO Makes Bold Move with Major Stock Purchase! - TipRanks
Rezolute Appoints Erik Harris to Board of Directors - TipRanks
Rezolute CFO Daron Evans acquires $57,700 in common shares - Investing.com India
Rezolute Inc (NASDAQ: RZLT): Getting A Free Pass? - Stocks Register
Rezolute expands board with biopharma veteran Erik Harris By Investing.com - Investing.com South Africa
Rezolute expands board with biopharma veteran Erik Harris - Investing.com
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - The Manila Times
Strategic Move: Ultragenyx CCO Erik Harris to Drive Rezolute's Rare Disease Commercialization - Stock Titan
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing - Nasdaq
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.38 - Defense World
JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Rating of "Buy" from Analysts - MarketBeat
A Guide To The Risks Of Investing In Rezolute Inc (RZLT) - Knox Daily
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India
Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey
Insider Trading Highlights: Wednesday's Key Moves in US Stocks - Investing.com
Short Interest in Rezolute, Inc. (NASDAQ:RZLT) Rises By 17.4% - MarketBeat
Rezolute director Kim Young-Jin buys $5 million in shares By Investing.com - Investing.com Australia
Rezolute director Kim Young-Jin buys $5 million in shares - Investing.com
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - MarketBeat
JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha
Rezolute’s SWOT analysis: biotech stock advances on ersodetug trials By Investing.com - Investing.com Nigeria
What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World
What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat
What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
Rezolute’s Strategic Advances in Rare Disease Therapies - MSN
Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
JMP Securities lifts Rezolute stock target to $9, maintains rating By Investing.com - Investing.com Australia
Finanzdaten der Rezolute Inc-Aktie (RZLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):